rss
Sex Transm Infect 2005;81:239-241 doi:10.1136/sti.2004.010413
  • In practice

Comparison of non-invasive sampling methods for detection of HPV in rural African women

  1. N Lack1,
  2. B West1,
  3. D Jeffries1,
  4. G Ekpo1,
  5. L Morison3,
  6. W P Soutter2,
  7. G Walraven1,
  8. L Boryseiwicz2
  1. 1MRC Laboratories, Fajara, PO Box 273, Banjul, Gambia
  2. 2Imperial College, London SW7 2AZ, UK
  3. 3London School of Hygiene and Tropical Medicine, London, UK
  1. Correspondence to:
 Dr Nicola Lack
 MRC Laboratories Fajara, Atlantic Boulevard, PO Box 273, Banjul, Gambia; nikkilackhotmail.com
  • Accepted 21 September 2004

Abstract

Background: The prevalence of cervical cancer is extremely high in low income countries, primarily because of a lack of cytological screening. The link between human papillomavirus (HPV) and cervical cancer has long been recognised, and it has been suggested that isolated HPV testing in women who do not participate in existing screening programmes may be used to identify women at higher risk of developing cervical cancer. This community based study compares two self administered techniques for detecting HPV (tampons and self administered swabs) with a clinician directed technique, the cervical cytobrush.

Methods: 377 rural women were interviewed and of these 210 women had full gynaecological examination, and accepted all three sampling methods for HPV. HPV typing of DNA extracts was performed using polymerase chain reaction and enzyme linked immunosorbent assay techniques.

Results: Using the cervical cytobrush as the gold standard, self administered swabs (SAS) showed a sensitivity of 63.9%, and tampons showed a sensitivity of 72.4%. The acceptability of these two tests was 97.1% and 84.6% respectively. When combining acceptability with sensitivity, the SAS detected 61.9% and the tampons detected 60.9% of the true positives.

Conclusion: In a setting where women are at a considerable risk of developing cervical cancer, with no access to a formal screening programme, self directed HPV testing could be a useful screening tool in identifying those women at increased risk who may require further investigation.

Footnotes

  • This work was supported by funding from the Medical Research Council (UK).

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.